Topics

FDA approves etanercept biosimilar Eticovo

05:16 EDT 3 May 2019 | Generics and Biosimilars Initiative

Korean biosimilars maker Samsung Bioepis (Samsung and Biogen’s joint venture) announced on 25 April 2019 that it had received approval from the US Food and Drug Administration (FDA) for its etanercept biosimilar.

Original Article: FDA approves etanercept biosimilar Eticovo

NEXT ARTICLE

More From BioPortfolio on "FDA approves etanercept biosimilar Eticovo"

Quick Search